We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Questions About Pivotal Trial Trip Up Abbott’s MitraClip
Questions About Pivotal Trial Trip Up Abbott’s MitraClip
March 22, 2013
An FDA advisory panel voted 5-3 that the benefits of Abbott Vascular’s MitraClip heart device outweigh the risks after a heated debate among FDA reviewers, the manufacturer and other stakeholders on the value of the device and the validity of a pivotal trial.